Roche Global Head Of Partnering Sophie Kornowski-Bonnet On Finding Innovation In Asia (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Sophie Kornowski-Bonnet sits down with PharmAsia News to share her impressions of innovation in China and the company’s overall partnering strategy in China and emerging markets.
You may also be interested in...
Will Innovation Replace Branded Generics As Dominant Strategy For Big Pharma In Emerging Markets? (Part 2 of 2)
[Editor's note: This is part two of a two-part story; part one appeared in PharmAsia News, March 4, 2011.]
Asia Spotlight: Ascendancy Healthcare CEO Sandy Zweifach On The Gap In China
Seeing a gap between the large infrastructure being built in China by multinational and domestic companies, Ascendancy hopes to be an interface to help China access drugs from the West.
Ascendancy Healthcare CEO Sandy Zweifach On The Gap In China: An Interview With PharmAsia News (Part 2 of 2)
Seeing a gap between the large infrastructure being built in China by multinational and domestic companies, Ascendancy hopes to be an interface to help China access drugs from the West.